• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictive Value of CCQ and its Subdomains for Hospitalized Exacerbations in Chronic Obstructive Pulmonary Disease: A 3-Year Observational Prospective Study.慢性阻塞性肺疾病患者住院急性加重期CCQ及其子领域的预测价值:一项为期3年的观察性前瞻性研究。
J Gen Intern Med. 2025 May;40(7):1550-1558. doi: 10.1007/s11606-024-09067-0. Epub 2024 Oct 1.
2
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后的肺康复治疗。
Cochrane Database Syst Rev. 2016 Dec 8;12(12):CD005305. doi: 10.1002/14651858.CD005305.pub4.
3
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表:Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
4
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
5
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
6
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病急性加重的简短患者教育行动计划。
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4.
7
Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.吸入性皮质类固醇联合吸入长效β2-激动剂和长效抗胆碱能药物治疗慢性阻塞性肺疾病。
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD011600. doi: 10.1002/14651858.CD011600.pub3.
8
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
9
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
10
Chronic non-invasive ventilation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的慢性无创通气。
Cochrane Database Syst Rev. 2021 Aug 9;8(8):CD002878. doi: 10.1002/14651858.CD002878.pub3.

本文引用的文献

1
Physical activity and outcomes in Japanese patients with chronic obstructive pulmonary disease: From the Ishinomaki COPD Network registry.体力活动与慢性阻塞性肺疾病日本患者结局的关系:来自磐城 COPD 网络注册研究。
Respir Investig. 2024 Jan;62(1):107-112. doi: 10.1016/j.resinv.2023.10.007. Epub 2023 Dec 14.
2
Clinical characteristics and risk of all-cause mortality in low education patients with chronic obstructive pulmonary disease in the Chinese population.中文人群中受教育程度低的慢性阻塞性肺疾病患者的临床特征及全因死亡率风险。
J Glob Health. 2023 Dec 1;13:04163. doi: 10.7189/jogh.13.04163.
3
Prediction of Hospitalization and Mortality in Patients with Chronic Obstructive Pulmonary Disease with the New Global Initiative for Chronic Obstructive Lung Disease 2023 Group Classification: A Prospective Cohort and a Retrospective Analysis.采用 2023 年新版全球慢性阻塞性肺疾病倡议组织分类预测慢性阻塞性肺疾病患者的住院和死亡风险:一项前瞻性队列研究和回顾性分析。
Int J Chron Obstruct Pulmon Dis. 2023 Oct 26;18:2341-2352. doi: 10.2147/COPD.S429104. eCollection 2023.
4
Frailty and its influence on mortality and morbidity in COPD: A Systematic Review and Meta-Analysis.衰弱及其对 COPD 患者死亡率和发病率的影响:系统评价和荟萃分析。
Intern Emerg Med. 2023 Nov;18(8):2423-2434. doi: 10.1007/s11739-023-03405-6. Epub 2023 Sep 5.
5
Is Frailty Diagnosis Important in Patients with COPD? A Narrative Review of the Literature.衰弱症诊断在 COPD 患者中重要吗?文献回顾的叙述性评论。
Int J Environ Res Public Health. 2023 Jan 17;20(3):1678. doi: 10.3390/ijerph20031678.
6
Generalizability of Risk Stratification Algorithms for Exacerbations in COPD.慢性阻塞性肺疾病急性加重风险分层算法的可推广性
Chest. 2023 Apr;163(4):790-798. doi: 10.1016/j.chest.2022.11.041. Epub 2022 Dec 9.
7
Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank.COPD 患者的衰弱:使用英国生物库进行的患病率和临床影响分析。
BMJ Open Respir Res. 2022 Jul;9(1). doi: 10.1136/bmjresp-2022-001314.
8
Predictors of mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病患者死亡的预测因素:系统评价和荟萃分析。
BMC Pulm Med. 2022 Apr 4;22(1):125. doi: 10.1186/s12890-022-01911-5.
9
Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary disease.比较 CAT 及短期内 CAT 变化对慢性阻塞性肺疾病未来恶化的预测价值。
Ann Med. 2022 Dec;54(1):875-885. doi: 10.1080/07853890.2022.2055134.
10
Frailty, a Dimension of Impaired Functional Status in Advanced COPD: Utility and Clinical Applicability.衰弱,一种晚期 COPD 患者功能状态受损的维度:实用性和临床适用性。
Medicina (Kaunas). 2021 May 11;57(5):474. doi: 10.3390/medicina57050474.

慢性阻塞性肺疾病患者住院急性加重期CCQ及其子领域的预测价值:一项为期3年的观察性前瞻性研究。

Predictive Value of CCQ and its Subdomains for Hospitalized Exacerbations in Chronic Obstructive Pulmonary Disease: A 3-Year Observational Prospective Study.

作者信息

Zhou Zijing, Cheng Wei, Liu Cong, Song Qing, Lin Ling, Zeng Yuqin, Deng Dingding, Ma Libing, Yu Zhiping, Yi Rong, Chen Ping

机构信息

Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Renmin Middle Road, No. 139, Changsha, 410011, Hunan, China.

Research Unit of Respiratory Disease, Central South University, Changsha, 410011, Hunan, China.

出版信息

J Gen Intern Med. 2025 May;40(7):1550-1558. doi: 10.1007/s11606-024-09067-0. Epub 2024 Oct 1.

DOI:10.1007/s11606-024-09067-0
PMID:39354255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12052719/
Abstract

BACKGROUND

The prediction capacity of the Clinical COPD Questionnaire (CCQ) and its functional, symptom, and mental subdomain for COPD hospitalized exacerbation were rarely studied.

OBJECTIVE

To examine the prognostic capacity of the total CCQ and its three subdomains for 3-year COPD hospitalized exacerbations.

METHODS

We analyzed the predictive ability of total CCQ score and its subdomains for hospitalized exacerbations in an observational cohort of 987 subjects with stable COPD from the RealDTC, an ongoing multicenter prospective study. Hospitalized exacerbations were prospectively collected every 6 month for a maximum of 3 years.

RESULTS

The total CCQ and its functional and symptom domain, but not the mental domain, were significantly associated with 3-year hospitalized exacerbations by multivariate Cox regression analysis. The predictive capacity of functional domain was similar to that of the total CCQ, but significantly stronger than the symptom and mental domain by ROC analysis (P < 0.05). ROC curves also showed that the AUC of exacerbation history combined with CCQ functional domain was larger than that of exacerbation history alone (P < 0.0001). Additionally, the predictive value of multivariable models that contains CCQ functional domain was significantly better than the corresponding model without CCQ functional domain (P < 0.05).

CONCLUSIONS

The total CCQ and its functional and symptom domain were independent risk factors of 3-year hospitalized exacerbations. The prognostic capacity of the functional domain was similar to that of total CCQ, and was significantly stronger than the symptom and mental domain. The CCQ functional domain was able to increase the predictive power of exacerbation history and other multivariable prediction models, indicating it may have an important role in the multivariable prediction tool for hospitalized exacerbation, and its combination with other clinical variables might be used as a low-cost approach for assessments of the disease severity and severe exacerbation in COPD patients in the future.

摘要

背景

临床慢性阻塞性肺疾病问卷(CCQ)及其功能、症状和心理子领域对慢性阻塞性肺疾病住院加重的预测能力鲜有研究。

目的

探讨CCQ总分及其三个子领域对慢性阻塞性肺疾病住院加重3年的预后能力。

方法

我们在一项正在进行的多中心前瞻性研究RealDTC中,分析了987例稳定期慢性阻塞性肺疾病患者的观察队列中,CCQ总分及其子领域对住院加重的预测能力。每6个月前瞻性收集住院加重情况,最长3年。

结果

通过多变量Cox回归分析,CCQ总分及其功能和症状领域(而非心理领域)与3年住院加重显著相关。功能领域的预测能力与CCQ总分相似,但通过ROC分析,其显著强于症状和心理领域(P<0.05)。ROC曲线还显示,加重病史与CCQ功能领域相结合的AUC大于单独加重病史的AUC(P<0.0001)。此外,包含CCQ功能领域的多变量模型的预测价值显著优于不包含CCQ功能领域的相应模型(P<0.05)。

结论

CCQ总分及其功能和症状领域是3年住院加重的独立危险因素。功能领域的预后能力与CCQ总分相似,且显著强于症状和心理领域。CCQ功能领域能够提高加重病史和其他多变量预测模型的预测能力,表明其可能在住院加重的多变量预测工具中发挥重要作用,其与其他临床变量的结合可能成为未来评估慢性阻塞性肺疾病患者疾病严重程度和严重加重的低成本方法。